Martin S Kluger PhD

Research Scientist in Immunobiology

Departments & Organizations

Vascular Biology and Therapeutics Program


Research Interests

Sepsis; Vascular Hyperpermeability (leak); Tumor Necrosis Factor (TNF); Interleukin-1 (IL-1); Claudin-5; Microvascular Endothelial Cells; NF-κB signaling more...


  • Ph.D., University of Connecticut, 1994

Selected Publications

  • Paul R. Clark, Richard K. Kim, Jordan S. Pober and Martin S. Kluger. TNF Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-kappaB Dependent Phases. Accepted (pending technical review) PLOS ONE.
  • *Kluger MS, Clark PR, Tellides G, Gerke V, Pober JS. Claudin-5 Controls Intercellular Barriers of Human Dermal Microvascular but not Human Umbilical Vein Endothelial Cells. 2013. Arteriosclerosis, Thrombosis, and Vascular Biology 33:489-500. Click to view: Access the recommendation on F1000Prime
  • *D’Alessio, A., * Kluger, M.S (*co-First Author), Li, J.H., Al-Lamki, R., Bradley, J.R., and Pober. J.S. Targeting of Tumor Necrosis Factor Receptor 1 to Low Density Plasma Membrane Domains in Human Endothelial Cells. 2010. Journal of Biological Chemistry. 285(31) 23868-23879



Latest News


Edit Profile